Virginia Rozalen Garcia, Tarek Ezzat Abdel-Aziz, Mechteld C de Jong, Francis Lam, Christina Soromani, John Honour, Tom R Kurzawinski
{"title":"即时钙离子检测:实验室验证和临床可行性研究。","authors":"Virginia Rozalen Garcia, Tarek Ezzat Abdel-Aziz, Mechteld C de Jong, Francis Lam, Christina Soromani, John Honour, Tom R Kurzawinski","doi":"10.1530/EC-25-0337","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients undergoing thyroid and parathyroid surgery require frequent assessment of blood calcium levels to guide their management, and currently such measurements are performed mostly in hospital environments on main laboratory platforms. The aim of this study was to explore the potential use of a non-medical LAQUA device designed to measure ionised calcium in environmental samples as a pocket-size point-of-care device able to measure blood calcium concentration in patients after thyroid and parathyroid surgery.</p><p><strong>Methods: </strong>The protocol of the study consisted of three distinctive phases: surveying the technological landscape and identifying currently available devices and technologies able to measure calcium in a small volume of whole blood easily, quickly, and accurately (Phase 1); testing the potential candidate device in a laboratory (Phase 2); and performing a prospective, single-arm study (IRAS ID 236079, Protocol number 18/0058, REC ref 19/LO/1740), during which simultaneous calcium measurements were performed on venous and capillary blood on LAQUA and 'gold standard' platforms Roche Cobas-Calcium-Gen.2 and Blood Gas Analyser ABL90 (Phase 3).</p><p><strong>Results: </strong>In Phase 1, LAQUA (HORIBA Inc. Japan) was identified as the most promising potential POC device in terms of size, simplicity of use, and cost effectiveness. In Phase 2, LAQUA showed good accuracy (Δmean = 0.09; P = 0.33) and precision (CV 3.41%) in measuring ionised calcium in standardised solutions. In Phase 3, 30 patients were recruited and had 67 sets of measurements. 'Gold standard' venous adjusted calcium (Roche) and ionised calcium (BGA) were equivalent, R = 0.95, (P < 0.001). Strong positive correlation R = 0.75 (P = <0.001) was observed between venous ionised calcium measured on BGA and LAQUA. Positive but weaker correlation was found between venous (BGA) and capillary (LAQUA) ionised calcium R = 0.68, (P = <0.001), and between venous and capillary ionised calcium (LAQUA), R = 0.56 (P = <0.001).</p><p><strong>Conclusions: </strong>LAQUA is a promising device, which can measure ionised calcium accurately in small venous but not yet capillary blood samples. Further device development is needed before it can be recommended as a potential POC device to measure calcium in blood.</p>","PeriodicalId":11634,"journal":{"name":"Endocrine Connections","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Point-of-care ionised calcium testing: lab validation and clinical feasibility study.\",\"authors\":\"Virginia Rozalen Garcia, Tarek Ezzat Abdel-Aziz, Mechteld C de Jong, Francis Lam, Christina Soromani, John Honour, Tom R Kurzawinski\",\"doi\":\"10.1530/EC-25-0337\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients undergoing thyroid and parathyroid surgery require frequent assessment of blood calcium levels to guide their management, and currently such measurements are performed mostly in hospital environments on main laboratory platforms. The aim of this study was to explore the potential use of a non-medical LAQUA device designed to measure ionised calcium in environmental samples as a pocket-size point-of-care device able to measure blood calcium concentration in patients after thyroid and parathyroid surgery.</p><p><strong>Methods: </strong>The protocol of the study consisted of three distinctive phases: surveying the technological landscape and identifying currently available devices and technologies able to measure calcium in a small volume of whole blood easily, quickly, and accurately (Phase 1); testing the potential candidate device in a laboratory (Phase 2); and performing a prospective, single-arm study (IRAS ID 236079, Protocol number 18/0058, REC ref 19/LO/1740), during which simultaneous calcium measurements were performed on venous and capillary blood on LAQUA and 'gold standard' platforms Roche Cobas-Calcium-Gen.2 and Blood Gas Analyser ABL90 (Phase 3).</p><p><strong>Results: </strong>In Phase 1, LAQUA (HORIBA Inc. Japan) was identified as the most promising potential POC device in terms of size, simplicity of use, and cost effectiveness. In Phase 2, LAQUA showed good accuracy (Δmean = 0.09; P = 0.33) and precision (CV 3.41%) in measuring ionised calcium in standardised solutions. In Phase 3, 30 patients were recruited and had 67 sets of measurements. 'Gold standard' venous adjusted calcium (Roche) and ionised calcium (BGA) were equivalent, R = 0.95, (P < 0.001). Strong positive correlation R = 0.75 (P = <0.001) was observed between venous ionised calcium measured on BGA and LAQUA. Positive but weaker correlation was found between venous (BGA) and capillary (LAQUA) ionised calcium R = 0.68, (P = <0.001), and between venous and capillary ionised calcium (LAQUA), R = 0.56 (P = <0.001).</p><p><strong>Conclusions: </strong>LAQUA is a promising device, which can measure ionised calcium accurately in small venous but not yet capillary blood samples. Further device development is needed before it can be recommended as a potential POC device to measure calcium in blood.</p>\",\"PeriodicalId\":11634,\"journal\":{\"name\":\"Endocrine Connections\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine Connections\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1530/EC-25-0337\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Connections","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/EC-25-0337","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"Print","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:接受甲状腺和甲状旁腺手术的患者需要经常评估血钙水平以指导其治疗,目前此类测量主要在医院环境下的主要实验室平台上进行。本研究的目的是探索一种非医用LAQUA设备的潜在用途,该设备设计用于测量环境样品中的电离钙,作为一种口袋大小的即时护理设备,能够测量甲状腺和甲状旁腺手术后患者的血钙浓度。方法:研究方案由3个不同的阶段组成,包括调查技术前景,确定当前可用的设备和技术,能够轻松、快速、准确地测量小体积全血中的钙(第一阶段),在实验室测试潜在的候选设备(第二阶段),并进行前瞻性单臂研究(IRAS ID 236079,协议号18/0058)。REC ref 19/LO/1740),在LAQUA和“金标准”平台Roche Cobas-Calcium-Gen上同时测量静脉血和毛细血管血中的钙含量。2和血气分析仪ABL90(第三期)。结果:在第一阶段,LAQUA (HORIBA Inc.Japan)在尺寸、使用简单性和成本效益方面被确定为最有潜力的POC设备。在第二阶段,LAQUA测量标准化溶液中离子钙具有良好的准确度(Δmean=0.09;p=0.33)和精密度(CV 3.41%)。在第三阶段,招募了30名患者,进行了67组测量。“金标准”静脉调节钙(罗氏)和离子钙(BGA)相当(R=0.95)。结论:LAQUA是一种很有前途的仪器,可以准确地测量小静脉但尚未毛细血管血液样品中的离子钙。在将其推荐为潜在的POC设备来测量血钙之前,需要进一步的设备开发。
Point-of-care ionised calcium testing: lab validation and clinical feasibility study.
Background: Patients undergoing thyroid and parathyroid surgery require frequent assessment of blood calcium levels to guide their management, and currently such measurements are performed mostly in hospital environments on main laboratory platforms. The aim of this study was to explore the potential use of a non-medical LAQUA device designed to measure ionised calcium in environmental samples as a pocket-size point-of-care device able to measure blood calcium concentration in patients after thyroid and parathyroid surgery.
Methods: The protocol of the study consisted of three distinctive phases: surveying the technological landscape and identifying currently available devices and technologies able to measure calcium in a small volume of whole blood easily, quickly, and accurately (Phase 1); testing the potential candidate device in a laboratory (Phase 2); and performing a prospective, single-arm study (IRAS ID 236079, Protocol number 18/0058, REC ref 19/LO/1740), during which simultaneous calcium measurements were performed on venous and capillary blood on LAQUA and 'gold standard' platforms Roche Cobas-Calcium-Gen.2 and Blood Gas Analyser ABL90 (Phase 3).
Results: In Phase 1, LAQUA (HORIBA Inc. Japan) was identified as the most promising potential POC device in terms of size, simplicity of use, and cost effectiveness. In Phase 2, LAQUA showed good accuracy (Δmean = 0.09; P = 0.33) and precision (CV 3.41%) in measuring ionised calcium in standardised solutions. In Phase 3, 30 patients were recruited and had 67 sets of measurements. 'Gold standard' venous adjusted calcium (Roche) and ionised calcium (BGA) were equivalent, R = 0.95, (P < 0.001). Strong positive correlation R = 0.75 (P = <0.001) was observed between venous ionised calcium measured on BGA and LAQUA. Positive but weaker correlation was found between venous (BGA) and capillary (LAQUA) ionised calcium R = 0.68, (P = <0.001), and between venous and capillary ionised calcium (LAQUA), R = 0.56 (P = <0.001).
Conclusions: LAQUA is a promising device, which can measure ionised calcium accurately in small venous but not yet capillary blood samples. Further device development is needed before it can be recommended as a potential POC device to measure calcium in blood.
期刊介绍:
Endocrine Connections publishes original quality research and reviews in all areas of endocrinology, including papers that deal with non-classical tissues as source or targets of hormones and endocrine papers that have relevance to endocrine-related and intersecting disciplines and the wider biomedical community.